Compounds > paraoxon
Page last updated: 2024-08-21

paraoxon and 3-phenylenediamine

paraoxon has been researched along with 3-phenylenediamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gichner, T; Plewa, MJ; Veleminský, J; Wagner, ED1
Gichner, T; Plewa, MJ; Repetny, K; Tan, JS; Wagner, ED1
Głogowska-Szelag, J; Kajdaniuk, D; Karpe, J; Kos-Kudła, B; Marek, B; Nowak, K; Nowak, M; Siemińska, L; Swietochowska, E; Wielkoszyński, T1

Other Studies

3 other study(ies) available for paraoxon and 3-phenylenediamine

ArticleYear
Mutagenic synergy between paraoxon and plant-activated m-phenylenediamine or 2-acetoxyacetylaminofluorene.
    Environmental and molecular mutagenesis, 1996, Volume: 27, Issue:1

    Topics: Acetoxyacetylaminofluorene; Acetyltransferases; Amidohydrolases; Antimutagenic Agents; Biotransformation; Drug Synergism; Enzyme Inhibitors; Mutagens; Nicotiana; Paraoxon; Phenylenediamines; Plant Extracts; Plants, Toxic; Prodrugs; Salmonella typhimurium

1996
Mutagenic synergy between paraoxon and mammalian or plant-activated aromatic amines.
    Environmental and molecular mutagenesis, 1997, Volume: 30, Issue:3

    Topics: Acetoxyacetylaminofluorene; Biotransformation; Drug Synergism; Mutagenicity Tests; Mutagens; Nicotiana; Paraoxon; Phenylenediamines; Plants, Toxic; Salmonella typhi

1997
Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
    Clinical and experimental medicine, 2010, Volume: 10, Issue:3

    Topics: Adult; Age Factors; Aged; Antioxidants; Aryldialkylphosphatase; C-Reactive Protein; Ceruloplasmin; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Paraoxon; Phenylenediamines; Sex Factors

2010